Tag: Dr Angus Forster
Vaxxas secures TGA licence to expand manufacturing of therapeutic goods in Brisbane
Australian biotechnology company Vaxxas has been granted a Therapeutic Goods Administration licence to manufacture therapeutic goods, clearing the way for GMP-compliant manufacturing at its Brisbane biomedical facility and supporting the progression of clinical trials for its proprietary high-density microarray patch technology.
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
